Pediatric Vaccine Market By Vaccine Type (Monovalent and Multivalent), By Administration Method (Oral, Intramuscular, and Subcutaneous), By Disease Type (Meningococcal Disease, Hepatitis, Influenza, Polio, Pneumococcal Disease, DTP, MMR, Dengue, Rotavirus, HPV, Varicella, Herpes Zoster, and Others), By Technology (Recombinant Vaccines, Inactivated Vaccines, Conjugate Vaccines, Toxoid Vaccines, and Live Attenuated Vaccines), and By End-User (Hospitals, Healthcare Providers, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

  • TBI610793
  • July 24, 2020
  • Global
  • 132 pages
  • SAC Insights
                                          

Abstract

The report analyzes and forecasts the pediatric vaccine market on a global and regional level. The study offers past data from 2016 to 2018 and a forecast from 2019 to 2025 based on revenue (USD Billion). The assessment of pediatric vaccine market gives a brief thought about the drivers and restraints of the pediatric vaccine market along with the impact they have on the demand over the years to come. Additionally, the report also includes the study of opportunities available in the pediatric vaccine market on a global level. The report gives a transparent view of the pediatric vaccine market. We have included a detailed competitive scenario and portfolio of the leading vendors operating in the pediatric vaccine market. To understand the competitive landscape in the pediatric vaccine market, an analysis of Porter’s Five Forces model has also been included. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness. The study provides a crucial view of the pediatric vaccine market by segmenting it based on the vaccine type, disease type, technology, administration method, end-user, and region. All the segments of the pediatric vaccine market have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment comprises the current and forecast demand for the Middle East and Africa, North America, Asia Pacific, Latin America, and Europe. Some key players operating in the global pediatric vaccine market are Mitsubishi Tanabe Pharma, Astellas Pharma, Johnson & Johnson, Pfizer, CSL Limited, GlaxoSmithKline, Serum Institute of India, Panacea Biotec, Daiichi Sankyo, and Merck. This report segment the global pediatric vaccine market into: Global Pediatric Vaccine Market: By Vaccine Type Monovalent Vaccines Multivalent Vaccines Global Pediatric Vaccine Market: By Disease Type Meningococcal Disease Hepatitis Influenza Polio Pneumococcal Disease DTP MMR (Measles, Mumps, and Rubella) Dengue Rotavirus Human Papilloma Virus (HPV) Varicella Herpes Zoster Others Global Pediatric Vaccine Market: By Technology Recombinant Vaccines Inactivated Vaccines Conjugate Vaccines Toxoid Vaccines Live Attenuated Vaccines Global Pediatric Vaccine Market: By Administration Method Oral Intramuscular Subcutaneous Global Pediatric Vaccine Market: By End-User Hospitals Healthcare Providers Others Global Pediatric Vaccine Market: By Region North America The U.S. Europe UK France Germany Asia Pacific China Japan India Latin America Brazil Middle East and Africa

Table of Contents
                    
                    
                         Request Table Of Content
                         Click To Request Sample
                    

	Chapter 1. Introduction
	
		1.1. Report description and scope
		1.2. Research scope
		1.3. Research methodology
		
			1.3.1. Market research process
			1.3.2. Market research methodology
		
		
	
	
	 
	Chapter 2. Executive Summary
	
		2.1. Global Pediatric Vaccine Market Revenue, 2016-2025 (USD Billion)
		2.2. Global Pediatric Vaccine Market: Snapshot
	
	
	 
	Chapter
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form